Full-Time
Sr. Associate Engineer
Polysaccharide Process Development
Updated on 4/25/2024
Develops broad-spectrum pneumococcal conjugate vaccines
Mid
San Carlos, CA, USA
- B.S./M.S. in bioengineering, chemical engineering, biochemistry or related disciplines with 3+ years of experience
- Prior experience with bioreactor fermentations, depth filtration, centrifugation, and TFF for primary recovery
- Experience with analytical methods such as plate-based assays, UV-spectrophotometry, and metabolite analyzers
- Experience writing technical documents including lab operation protocols and data summary reports
- Proficiency in Microsoft Excel, Word, and Powerpoint
- Experience with statistical software such as JMP, R studio, python, etc.
- Familiarity with statistical methods for process characterization and validation
- Familiarity with DOE principles and experience with DoE software (JMP)
- Some experience with GXP requirements including deviation investigations, CAPAs, and change controls
- Understanding of engineering principles for scaling upstream unit operations
- Assist in designing and executing process development runs
- Operate and maintain instrumentation including BSL2 microbial fermenters, TFF systems, depth filtration, and centrifugation
- Record data in electronic laboratory notebooks and write technical summary reports
- Perform analytical assays for process development and in-process manufacturing samples
- Perform statistical analysis for manufacturing in-process data
- Present data to the team and contribute to technical discussions
- Review manufacturing documents and transfer in-process data to repositories
Vaxcyte is dedicated to developing a range of high-fidelity, broad-spectrum vaccines, including VAX-24, a 24-valent pneumococcal conjugate vaccine. Leveraging advanced chemistry and the proprietary XpressCF™ cell-free protein synthesis platform, the company stands out in the biotechnology field for its targeted approach to combating serious bacterial infections. This focus on cutting-edge technology and a strong pipeline of innovative vaccine candidates makes it an exciting workplace for professionals passionate about impacting global health through scientific breakthroughs.
Company Stage
IPO
Total Funding
$2.3B
Headquarters
San Carlos, California
Founded
2013